Trials / Conditions / Streptococcal Infections

Streptococcal Infections

24 registered clinical trials studyying Streptococcal Infections — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Heal NCT07017777	CanSino Biologics Inc.	Phase 3
Recruiting	Factors Associated With Mortality in Streptococcal Anginosus Bacteremia NCT07343167	University Hospital, Strasbourg, France	—
Recruiting	A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Alu NCT07085702	GlaxoSmithKline	Phase 1
Completed	Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i) NCT04841369	CanSino Biologics Inc.	Phase 3
Completed	Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above NCT04100772	CanSino Biologics Inc.	Phase 1
Completed	Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyop NCT02270944	GlaxoSmithKline	Phase 2
Completed	Efficacy of Propolis Varnish Against Oral Biofilm NCT02052973	Federal University of Minas Gerais	Phase 1 / Phase 2
Completed	Rapid Strep Testing in Children With Recent Streptococcal Pharyngitis NCT03055728	Georgetown University	—
Completed	Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative P NCT01412801	Novartis Vaccines	Phase 2
Completed	Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of NCT01193920	Novartis Vaccines	Phase 1 / Phase 2
Completed	Oral Health Literacy Tailored Communication NCT01118143	University of Tromso	N/A
Withdrawn	Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure NCT00598429	NICHD Neonatal Research Network	Phase 2
Completed	Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections NCT00646958	Melinta Therapeutics, Inc.	Phase 2
Completed	A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years o NCT01026636	Basilea Pharmaceutica	Phase 1
Completed	A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients NCT01026558	Basilea Pharmaceutica	Phase 1
Completed	A Study for Patients With Complicated Skin and Skin Structure Infections NCT00514527	Targanta Therapeutics Corporation	Phase 2
Completed	Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers NCT01026740	Basilea Pharmaceutica	Phase 1
Completed	Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease NCT01030731	Basilea Pharmaceutica	Phase 1
Withdrawn	Rapid Detection of Group B Streptococcus (Strep)-Labor and Delivery Study NCT00330642	University of Michigan	—
Completed	Long Term Follow-up of Patients With Group A Streptococcal Infection Originating From the Genital Tract NCT00299663	Hadassah Medical Organization	—
Terminated	Comparative Trial of Oral Penicillin Versus Cefuroxim for Treatment of Perianal Streptococcal Dermatitis NCT00261742	University Children's Hospital Basel	Phase 4
Completed	A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine NCT00169481	GlaxoSmithKline	Phase 2
Completed	Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territo NCT00884728	Menzies School of Health Research	—
Completed	Treatment of Group A Beta Hemolytic Streptococcal Pharyngitis in Children in Low Resource Settings NCT01156740	Johns Hopkins University	N/A